Horizon Kinetics Asset Management’s 2seventy bio TSVT Stock Holding History

Horizon Kinetics Asset Management’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,275	Closed	-$85.3K	–	361
2025 Q1	$85.3K	Hold	17,275	–	–	﹤0.01%	332
2024 Q4	$50.8K	Buy	17,275 +725	+4%	+$2.97K	﹤0.01%	340
2024 Q3	$78.1K	Sell	16,550 -725	-4%	-$3.27K	﹤0.01%	331
2024 Q2	$66.5K	Hold	17,275	–	–	﹤0.01%	314
2024 Q1	$92.4K	Hold	17,275	–	–	﹤0.01%	311
2023 Q4	$73.8K	Sell	17,275 -725	-4%	-$2.23K	﹤0.01%	313
2023 Q3	$70.6K	Hold	18,000	–	–	﹤0.01%	318
2023 Q2	$182K	Hold	18,000	–	–	﹤0.01%	296
2023 Q1	$184K	Buy	+18,000	New	+$206K	﹤0.01%	297

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Horizon Kinetics Asset Management's TSVT Position: Q2 2025 in Review

Horizon Kinetics Asset Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 17,275 shares — an estimated $85.3K sold.

Horizon Kinetics Asset Management first reported a position in TSVT in Q1 2023 and held it in 9 quarters. The position peaked at $184K in Q1 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Horizon Kinetics Asset Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Horizon Kinetics Asset Management sold 17,275 2seventy bio shares in Q2 2025, an estimated $85.3K.
Horizon Kinetics Asset Management first reported a position in 2seventy bio in Q1 2023 and held it in 9 quarters.
Horizon Kinetics Asset Management's 2seventy bio position peaked at $184K in Q1 2023.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.